Identification of tumor-specific MRI biomarkers using machine learning (ML)

R Hajjo, DA Sabbah, SK Bardaweel, A Tropsha - Diagnostics, 2021 - mdpi.com
The identification of reliable and non-invasive oncology biomarkers remains a main priority
in healthcare. There are only a few biomarkers that have been approved as diagnostic for …

[HTML][HTML] Self-supervised learning methods for label-efficient dental caries classification

A Taleb, C Rohrer, B Bergner, G De Leon… - Diagnostics, 2022 - mdpi.com
High annotation costs are a substantial bottleneck in applying deep learning architectures to
clinically relevant use cases, substantiating the need for algorithms to learn from unlabeled …

Detection of bone metastases on bone scans through image classification with contrastive learning

TC Hsieh, CW Liao, YC Lai, KM Law, PK Chan… - Journal of personalized …, 2021 - mdpi.com
Patients with bone metastases have poor prognoses. A bone scan is a commonly applied
diagnostic tool for this condition. However, its accuracy is limited by the nonspecific …

Identifying non-math students from brain mris with an ensemble classifier based on subspace-enhanced contrastive learning

S Liu, Y Zhang, J Peng, T Wang, X Shang - Brain Sciences, 2022 - mdpi.com
In current research processes, mathematical learning has significantly impacted the brain's
plasticity and cognitive functions. While biochemical changes in brain have been …

[PDF][PDF] Self-Supervised Learning Methods for Label-Efficient Dental Caries Classification. Diagnostics 2022, 12, 1237

A Taleb, C Rohrer, B Bergner, G De Leon… - 2022 - academia.edu
High annotation costs are a substantial bottleneck in applying deep learning architectures to
clinically relevant use cases, substantiating the need for algorithms to learn from unlabeled …

[PDF][PDF] Identification of Tumor-specific MRI Biomarkers Using Machine Learning (ML). Diagnostics 2021, 11, 742

R Hajjo, DA Sabbah, SK Bardaweel, A Tropsha - 2021 - pdfs.semanticscholar.org
The identification of reliable and non-invasive oncology biomarkers remains a main priority
in healthcare. There are only a few biomarkers that have been approved as diagnostic for …